The government-funded venture capital firm TMF Management Co (TMF管顧公司) yesterday said it is talking to several public and private investors to raise as much as NT$5 billion (US$172.89 million) by December, with the aim of putting Taiwan on the global biotech map.
The fund, called Taiwan Medtech Fund (TMF), got an injection of NT$1 billion from the Executive Yuan’s National Development Fund in June.
State-run firms including CPC Corp, Taiwan (台灣中油), China Steel Corp (中鋼), Taiwan Sugar Corp (台糖) and Taiwan Salt Co (台鹽) are involved in the talks and their combined investments will be not exceed NT$1 billion, TMF Management chairman Jang Yue-teh (張有德) said.
“We are also looking to private firms for capital,” he told reporters, adding that investor targets include entrepreneurs who have passion for medical health, especially those who have experience in the field or who had family members that have suffered from serious illnesses.
Hon Hai Group (鴻海集團) chairman Terry Gou’s (郭台銘) younger brother died of bone marrow cancer, while Quanta Computer Inc (廣達) chairman Barry Lam (林百里) has battled lung cancer.
When asked if firms such as Hon Hai were on the target list, Jang declined to comment, but said there would be more announcements soon.
“Taiwan has been talking about developing its biotech sector for more than 20 years,” he said. “But progress is going nowhere given a lack of talent, capital and an understanding of its importance.”
The venture capitalist plans to set up incubation centers that will generate, develop and -commercialize new ideas, and help market the end products in China, where the huge market could lead to big sales possibilities, said Stan Shih (施振榮), chairman of iD SoftCapital Inc (智融集團) and the founder of Acer Group (宏碁集團).
iD SoftCapital was invited by TMF Management to share its experiences and the former has not ruled out the possibility of investing in some projects.
The incubation centers would generate ideas mainly through research institutes and from academics, although they may come from anywhere in the world, as long as the ideas benefit Taiwan in certain ways, Jang said.
He said viable projects would either need to have their products produced here, or include -Taiwanese research and development teams, or Taiwan would have to have a say in the commercialization of the product, he said.
TMF is looking to invest in projects that research illnesses such as diabetes, sleeping disorders, cardiovascular disease and in fields including neurosciences and orthopedics, as well as remote and home-care medical services.
Jang is a partner in the US-based Vertical Group, a venture capital firm focused on medical technology and biotechnology.
He has more than 20 years of experience in various executive positions in the healthcare industry and currently serves on the boards of directors of Dynamic Implants, Forte Bio Inc and Inphenix Corp.
Prior to the Vertical Group, he was president and CEO of Embol-X, a private company engaged in the development of proprietary medical devices to prevent strokes during cardiac surgery.
RECYCLE: Taiwan would aid manufacturers in refining rare earths from discarded appliances, which would fit the nation’s circular economy goals, minister Kung said Taiwan would work with the US and Japan on a proposed cooperation initiative in response to Beijing’s newly announced rare earth export curbs, Minister of Economic Affairs Kung Ming-hsin (龔明鑫) said yesterday. China last week announced new restrictions requiring companies to obtain export licenses if their products contain more than 0.1 percent of Chinese-origin rare earths by value. US Secretary of the Treasury Scott Bessent on Wednesday responded by saying that Beijing was “unreliable” in its rare earths exports, adding that the US would “neither be commanded, nor controlled” by China, several media outlets reported. Japanese Minister of Finance Katsunobu Kato yesterday also
China Airlines Ltd (CAL, 中華航空) said it expects peak season effects in the fourth quarter to continue to boost demand for passenger flights and cargo services, after reporting its second-highest-ever September sales on Monday. The carrier said it posted NT$15.88 billion (US$517 million) in consolidated sales last month, trailing only September last year’s NT$16.01 billion. Last month, CAL generated NT$8.77 billion from its passenger flights and NT$5.37 billion from cargo services, it said. In the first nine months of this year, the carrier posted NT$154.93 billion in cumulative sales, up 2.62 percent from a year earlier, marking the second-highest level for the January-September
‘DRAMATIC AND POSITIVE’: AI growth would be better than it previously forecast and would stay robust even if the Chinese market became inaccessible for customers, it said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday raised its full-year revenue growth outlook after posting record profit for last quarter, despite growing market concern about an artificial intelligence (AI) bubble. The company said it expects revenue to expand about 35 percent year-on-year, driven mainly by faster-than-expected demand for leading-edge chips for AI applications. The world’s biggest contract chipmaker in July projected that revenue this year would expand about 30 percent in US dollar terms. The company also slightly hiked its capital expenditure for this year to US$40 billion to US$42 billion, compared with US$38 billion to US$42 billion it set previously. “AI demand actually
Jensen Huang (黃仁勳), founder and CEO of US-based artificial intelligence chip designer Nvidia Corp and Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) on Friday celebrated the first Nvidia Blackwell wafer produced on US soil. Huang visited TSMC’s advanced wafer fab in the US state of Arizona and joined the Taiwanese chipmaker’s executives to witness the efforts to “build the infrastructure that powers the world’s AI factories, right here in America,” Nvidia said in a statement. At the event, Huang joined Y.L. Wang (王英郎), vice president of operations at TSMC, in signing their names on the Blackwell wafer to
RSS